Clinical Trials Logo

Frailty in Aging clinical trials

View clinical trials related to Frailty in Aging.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01833078 Completed - Frailty in Aging Clinical Trials

Ghrelin Repeated Dose Study

GRD
Start date: February 2013
Phase: Phase 2
Study type: Interventional

Frailty is a geriatric syndrome leading to physical deterioration including muscle wasting (sarcopenia) and unintentional weight loss. There are currently no approved therapies for frailty. Ghrelin is a hormone produced by the stomach that stimulates appetite centers in the brain. The investigators already know that a single dose of Ghrelin improves food intake immediately after the dose in frail older people. In this study, the investigators are trying to find out if repeated daily doses of ghrelin will help frail older people improve food intake for multiple days in a row.